JGC
MXCT icon

J. Goldman & Co’s MaxCyte MXCT Stock Holding History

J. Goldman & Co’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
+99,728
New +$99.4K ﹤0.01% 654
2023
Q2 		– Sell
-175,000
Closed -$866K – 456
2023
Q1 		$866K Buy
+175,000
New +$862K 0.04% 238

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

J. Goldman & Co's MXCT Position: Q2 2026 in Review

J. Goldman & Co opened a new position in MaxCyte (MXCT) in Q2 2026: 99,728 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #654 among its holdings. This is a return to the name: J. Goldman & Co previously reported a position in MXCT as recently as Q1 2023.

J. Goldman & Co first reported a position in MXCT in Q1 2023 and has held it in 2 quarters since. The position peaked at $866K in Q1 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • J. Goldman & Co held 99,728 shares of MaxCyte worth $123K as of Q2 2026.
  • MaxCyte was a new J. Goldman & Co position in Q2 2026.
  • MaxCyte made up ﹤0.01% of J. Goldman & Co's portfolio in Q2 2026, its #654 holding.
  • J. Goldman & Co first reported a position in MaxCyte in Q1 2023 and has held it in 2 quarters since.
  • J. Goldman & Co's MaxCyte position peaked at $866K in Q1 2023.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on J. Goldman & Co's 13F filing for Q2 2026, filed 14 Aug 2026.